Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2024-11-29 2024-11-29
Drug Identification Number 02417022 02417022
Brand name RIVASTIGMINE RIVASTIGMINE
Common or Proper name RIVASTIGMINE RIVASTIGMINE
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients RIVASTIGMINE RIVASTIGMINE
Strength(s) 6MG 6MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2025-07-31 2025-07-31
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments Looking to transfert to another supplier Looking to transfert to another supplier
Health Canada comments